Brief: Bajaj Healthcare's API Manufacturing Site At Vadodara Gets Approval From TGA Australia
06/12/2024 12:49
Dec 6 (Reuters) - Bajaj Healthcare Ltd BAJH.NS :
* APPROVAL FROM THERAPEUTIC GOODS ADMINISTRATION (TGA),
AUSTRALIA
* CO'S API MANUFACTURING SITE AT VADODARA GETS APPROVAL FROM
TGA
AUSTRALIA
* VADODARA SITE HAS ALREADY RECEIVED APPROVAL FROM USFDA AND
EU
* TGA APPROVAL VALID FOR 24 MONTHS
Source text: ID:nBSE374MtW
Further company coverage: BAJH.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bajaj Healthcare
See all newsBrief: Bajaj Healthcare Ltd Posts March-Quarter Loss 228.5 Million Rupees
Brief: Bajaj Healthcare Posts Dec-Quarter Profit Of 156.7 Million Rupees
Brief: Bajaj Healthcare Receives CDSCO Approval For Suvorexant Tablets Trial
India's Bajaj Healthcare rises as insomnia pill trial gets regulatory nod
Brief: Bajaj Healthcare Posts June-Quarter Profit Of 118.3 Million Rupees